Northern Trust Corp Glycomimetics Inc Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Glycomimetics Inc stock. As of the latest transaction made, Northern Trust Corp holds 116,985 shares of GLYC stock, worth $36,265. This represents 0.0% of its overall portfolio holdings.

Number of Shares

116,985

Previous 127,792 8.46%

Holding current value

$36,265

Previous $35,000 45.71%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$0.16 - $0.32 $1,729 - $3,458	-10,807 Reduced 8.46%	116,985 $19,000
Q2 2024 Aug 14, 2024	SELL	$0.24 - $3.04 $231 - $2,933	-965 Reduced 0.75%	127,792 $35,000
Q1 2024 May 14, 2024	BUY	$2.55 - $3.49 $44,632 - $61,085	17,503 Added 15.73%	128,757 $386,000
Q4 2023 Feb 13, 2024	BUY	$1.13 - $2.54 $5,670 - $12,745	5,018 Added 4.72%	111,254 $262,000
Q3 2023 Nov 13, 2023	SELL	$1.29 - $1.73 $18,881 - $25,322	-14,637 Reduced 12.11%	106,236 $159,000
Q2 2023 Aug 11, 2023	BUY	$1.21 - $2.08 $21,973 - $37,772	18,160 Added 17.68%	120,873 $210,000
Q1 2023 May 15, 2023	BUY	$1.25 - $4.05 $6,326 - $20,497	5,061 Added 5.18%	102,713 $129,000
Q4 2022 Feb 13, 2023	SELL	$0.57 - $3.03 $82 - $439	-145 Reduced 0.15%	97,652 $295,000
Q1 2022 May 13, 2022	SELL	$1.0 - $1.58 $690 - $1,090	-690 Reduced 0.7%	97,797 $111,000
Q4 2021 Feb 08, 2022	BUY	$1.44 - $2.14 $894 - $1,328	621 Added 0.63%	98,487 $142,000
Q3 2021 Nov 15, 2021	SELL	$1.8 - $2.39 $19,524 - $25,924	-10,847 Reduced 9.98%	97,866 $214,000
Q2 2021 Aug 13, 2021	SELL	$2.16 - $3.18 $598,447 - $881,047	-277,059 Reduced 71.82%	108,713 $252,000
Q1 2021 May 12, 2021	SELL	$2.89 - $4.22 $134,861 - $196,926	-46,665 Reduced 10.79%	385,772 $1.16 Million
Q4 2020 Feb 11, 2021	SELL	$2.69 - $4.24 $44,866 - $70,718	-16,679 Reduced 3.71%	432,437 $1.63 Million
Q3 2020 Nov 16, 2020	BUY	$3.07 - $5.0 $25,063 - $40,820	8,164 Added 1.85%	449,116 $1.38 Million
Q2 2020 Aug 14, 2020	SELL	$2.06 - $3.76 $6,336 - $11,565	-3,076 Reduced 0.69%	440,952 $1.66 Million
Q1 2020 May 14, 2020	BUY	$1.83 - $5.41 $21,317 - $63,021	11,649 Added 2.69%	444,028 $1.01 Million
Q4 2019 Feb 14, 2020	SELL	$4.03 - $6.5 $42,649 - $68,789	-10,583 Reduced 2.39%	432,379 $2.29 Million
Q3 2019 Nov 13, 2019	SELL	$2.8 - $12.85 $68,986 - $316,598	-24,638 Reduced 5.27%	442,962 $1.91 Million
Q2 2019 Aug 13, 2019	BUY	$10.6 - $13.12 $87,344 - $108,108	8,240 Added 1.79%	467,600 $5.57 Million
Q1 2019 May 13, 2019	BUY	$9.96 - $13.44 $171,003 - $230,751	17,169 Added 3.88%	459,360 $5.72 Million
Q4 2018 Feb 12, 2019	SELL	$8.47 - $14.71 $48,016 - $83,390	-5,669 Reduced 1.27%	442,191 $4.19 Million
Q3 2018 Nov 14, 2018	BUY	$13.7 - $17.12 $435,221 - $543,868	31,768 Added 7.63%	447,860 $6.45 Million
Q2 2018 Sep 18, 2018	SELL	$14.63 - $19.19 $33,166 - $43,503	-2,267 Reduced 0.54%	416,092 $6.71 Million
Q2 2018 Aug 14, 2018	BUY	$14.63 - $19.19 $4.88 Million - $6.41 Million	333,848 Added 395.03%	418,359 $6.75 Million
Q1 2018 May 09, 2018	BUY	$16.06 - $25.35 $238,780 - $376,903	14,868 Added 21.35%	84,511 $1.37 Million
Q4 2017 Feb 14, 2018	BUY	$10.51 - $17.22 $203,547 - $333,499	19,367 Added 38.52%	69,643 $1.17 Million
Q3 2017 Nov 13, 2017	BUY	$10.14 - $14.85 $509,798 - $746,598	50,276	50,276 $703,000

Others Institutions Holding GLYC

# of Institutions

Shares Held

17.8M

Call Options Held

Put Options Held

View Full List

About GLYCOMIMETICS INC

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $16.3M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

More about GLYC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Glycomimetics Inc Transaction History